Keurig Dr Pepper (KDP) Could Be 13% Below Fair Value As New Launches Meet Mixed Earnings

Keurig Dr Pepper

Keurig Dr Pepper

KDP

0.00

Keurig Dr Pepper (KDP) is drawing fresh attention after rolling out a lime led reformulation across its 7UP range and unveiling a limited time Dr Pepper Shake collaboration with Portillo’s, shortly after releasing mixed quarterly earnings.

For investors, the recent 7UP refresh and Dr Pepper Shake launch come after a mixed earnings release and a period where Keurig Dr Pepper’s share price has shown improving short term momentum, with a 90 day share price return of 7.92% and a year to date share price return of 12.01%, yet the 1 year total shareholder return is still down 8.74%.

If you are weighing Keurig Dr Pepper’s latest moves against other opportunities in the market, this can be a good moment to broaden your search with 21 top founder-led companies

After the 7UP overhaul, the Portillo’s partnership and a mixed earnings print, Keurig Dr Pepper’s shares have climbed in recent months yet remain below their 1 year mark. Is most of the rerating already done, or is there still clear upside ahead based on valuation?

Most Popular Narrative: 12.9% Undervalued

Keurig Dr Pepper’s most followed narrative pegs fair value at about $35.65 per share, above the last close of $31.06, which sets up a clear valuation gap for investors to interrogate.

The analysts have a consensus price target of $35.65 for Keurig Dr Pepper based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $42.0, and the most bearish reporting a price target of just $28.0.

Want to understand why this narrative still sees upside from $31.06 to the mid $30s? The key lies in how revenue, margins and future earnings are expected to evolve, and the profit multiple that ties those forecasts together.

This widely followed narrative applies a 7.24% discount rate and blends assumptions about Keurig Dr Pepper’s revenue trajectory, profit margins and future P/E multiple into a single fair value estimate around $35.65 per share.

Instead of relying only on today’s P/E of 31.4x, it works backwards from implied earnings power and a lower future earnings multiple, then discounts those cash flows and earnings back using that 7.24% hurdle.

The outcome is a fair value that sits above the current $31.06 share price, although the discount to that narrative fair value is not extreme, which leaves room for different views on whether the current market price already reflects much of the story.

Result: Fair Value of $35.65 (UNDERVALUED)

However, this Keurig Dr Pepper narrative still hinges on key swing factors, including ongoing pressure in U.S. Coffee and execution risk related to the planned Global Coffee separation.

Another View: Keurig Dr Pepper Looks Expensive On Earnings

While the analyst narrative points to around 12.9% upside to a fair value near $35.65, the current P/E of 31.4x tells a much tougher story for Keurig Dr Pepper. That multiple is higher than the global beverage industry at 17.4x, above the peer average of 25.4x, and even above the 25.4x fair ratio that our models suggest the market could move toward.

If earnings growth or margins fall short of expectations, a move closer to that 25.4x fair ratio would imply valuation risk rather than upside. The question for you is whether today’s price compensates enough for that gap in multiples.

NasdaqGS:KDP P/E Ratio as at Aug 2026
NasdaqGS:KDP P/E Ratio as at Aug 2026

Next Steps

If the mixed signals on Keurig Dr Pepper leave you unsure, this is a good time to review the numbers and sentiment yourself and decide how comfortable you feel with both the downside and upside. To help frame that view in a structured way, take a closer look at the 2 key rewards and 4 important warning signs.

Looking for more investment ideas beyond Keurig Dr Pepper?

If Keurig Dr Pepper has you thinking more carefully about pricing, growth and risk, use this momentum to scan wider opportunities before the market moves on.

  • Target resilient compounding potential by checking companies in the 52 high quality undervalued stocks that pair quality fundamentals with prices that may not fully reflect their strengths.
  • Prioritise staying power in tougher conditions and review stocks in the solid balance sheet and fundamentals stocks screener (50 results) that combine financial stability with consistent execution.
  • Get ahead of the crowd by spotting future standouts through the screener containing 20 high quality undiscovered gems, where strong fundamentals meet lower market attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.